Dossier assessment
Olopatadine/mometasone furoate (allergic rhinitis) – Addendum to Commission A22-125
Report documents
-
Addendum
Olopatadine/mometasone furoate (allergic rhinitis) – Addendum to Commission A22-125
Additional information
Federal Joint Committee (G-BA)
2023-06-01 A G-BA decision was published.
Project details
- Project no.
- G23-09
- Commission
- Commission awarded on 27.04.2023 by the Federal Joint Committee (GBA).
- Report type
- Dossier assessment
- Status
- Commission completed
- Department/Division
- Health Economics
- Topic
- Airways and respiratory system
- Note
-
If, in the course of the discussions on a commission of the GBA, a need for further revision arises, IQWiG submits an addendum. The GBA decides on the number of patients in the SHI target population.
Connected Projects
-
Dossier assessment
Olopatadine/mometasone (allergic rhinitis) – Benefit assessment according to §35a Social Code Book V
Status: Commission completed